Search Count: 28
 |
C-Terminal Bromodomain Of Human Brd2 With 1,5-Dimethyl-N-(2-(Methylamino)-2-Oxo-1-(Tetrahydro-2H-Pyran-4-Yl)Ethyl)-6-Oxo-N-(2-Phenyl-2-(Pyridin-2-Yl)Ethyl)-1,6-Dihydropyridine-3-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.41 Å Release Date: 2021-10-13 Classification: NUCLEAR PROTEIN Ligands: 80Z, EDO, PE4 |
 |
C-Terminal Bromodomain Of Human Brd2 With N-Methyl-4-Propionyl-1H-Pyrrole-2-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2021-07-28 Classification: NUCLEAR PROTEIN Ligands: EDO, PE4, V9B |
 |
C-Terminal Bromodomain Of Human Brd2 With N5-Hydroxycyclohexyl-N3-Methyl-1-Phenylethyl-1H-Pyrazole-3,5-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-28 Classification: NUCLEAR PROTEIN Ligands: V9H, EDO |
 |
C-Terminal Bromodomain Of Human Brd2 With N4-Hydroxycyclohexyl-N2-Methyl-5-Phenylethyl-Furan-2,4-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.76 Å Release Date: 2021-07-28 Classification: NUCLEAR PROTEIN Ligands: V9K, EDO |
 |
C-Terminal Bromodomain Of Human Brd2 With 1-Benzyl-N5-Cyclopropyl-N3-Methyl-1H-Pyrazole-3,5-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-28 Classification: NUCLEAR PROTEIN Ligands: EDO, VE5, PEG |
 |
C-Terminal Bromodomain Of Human Brd2 With 6-Benzyl-N2-Methyl-N4-((1S,2S)-2-Methylcyclopropyl)Pyridine-2,4-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: UL5, EDO |
 |
C-Terminal Bromodomain Of Human Brd2 With (R)-N5-Cyclopropyl-N3-Methyl-2-Oxo-1-(1-Phenylethyl)-1,2-Dihydropyridine-3,5-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.28 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: EDO, ULH |
 |
C-Terminal Bromodomain Of Human Brd2 With Oxabicyclo(Hexan-6-Yl)-N2-Methyl-6-((S)-1-Phenylethyl)Pyridine-2,4-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: EDO, PE4, ULN |
 |
C-Terminal Bromodomain Of Human Brd2 With 6-((S)-Hydroxy(Phenyl)Methyl)-N2-Methyl-N4-((1S,2S)-2-Methylcyclopropyl)Pyridine-2,4-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: EDO, ULK |
 |
C-Terminal Bromodomain Of Human Brd2 With (S)-N4-Cyclopropyl-N2-Methyl-6-(1-Phenylethyl)Pyridine-2,4-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.74 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: ULE, EDO |
 |
C-Terminal Bromodomain Of Human Brd2 With N4-((1R,5S,6R)-3-Oxabicyclo[3.1.0]Hexan-6-Yl)-6-((S)-Methoxy(Phenyl)Methyl)-N2-Methylpyridine-2,4-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: EDO, ULQ |
 |
C-Terminal Bromodomain Of Human Brd4 N-(2,2-Diphenylethyl)-4-Methoxy-3,5-Dimethyl-N-(2-(Methylamino)-2-Oxoethyl)Benzamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.51 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: V9Z |
 |
C-Terminal Bromodomain Of Human Brd2 With 5-(1-(1,3-Dimethoxypropan-2-Yl)-5-Morpholino-1H-Benzo[D]Imidazol-2-Yl)-1,3-Dimethylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: EDO, PE4, NV2 |
 |
C-Terminal Bromodomain Of Human Brd2 With N-(2,2-Diphenylethyl)-1,5-Dimethyl-N-(2-(Methylamino)-2-Oxoethyl)-6-Oxo-1,6-Dihydropyridine-3-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: VBH, EDO |
 |
C-Terminal Bromodomain Of Human Brd2 With 1,5-Dimethyl-N-(2-(Methylamino)-2-Oxoethyl)-6-Oxo-N-(2-Phenylpropyl)-1,6-Dihydropyridine-3-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: EDO, PE4, VBE |
 |
C-Terminal Bromodomain Of Human Brd2 With N-Ethyl-2-(1-Methyl-1H-1,2,3-Triazol-4-Yl)-6-(1-Phenylethyl)Isonicotinamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.73 Å Release Date: 2021-04-07 Classification: NUCLEAR PROTEIN Ligands: UME, EDO, PEG |
 |
C-Terminal Bromodomain Of Human Brd2 With 3-(2-(Benzyloxy)Phenyl)-5-Methyl-1H-1,2,4-Triazole
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-03-24 Classification: NUCLEAR PROTEIN Ligands: EDO, PE4, ULB |
 |
C-Terminal Bromodomain Of Human Brd2 With (S)-N-Ethyl-3-(1-Methyl-1H-1,2,3-Triazol-4-Yl)-4-(1-Phenylethoxy)Benzamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2021-03-24 Classification: NUCLEAR PROTEIN Ligands: EDO, UL8 |
 |
C-Terminal Bromodomain Of Human Brd2 With N-Ethyl-3-(1-Methyl-1H-1,2,3-Triazol-4-Yl)-4-(Pyridin-2-Ylmethoxy)Benzamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-03-24 Classification: NUCLEAR PROTEIN Ligands: EDO, UM5 |
 |
C-Terminal Bromodomain Of Human Brd2 With 2-Benzyl-N-Cyclopropyl-6-(1-Methyl-1H-1,2,3-Triazol-4-Yl)Isonicotinamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-03-24 Classification: NUCLEAR PROTEIN Ligands: UMB, EDO |